Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer
Clinical trial NCT03557918 · COMPLETED
Trial details
- NCT number
- NCT03557918
- Sponsor
- Matthew Galsky
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-12
- Primary completion
- 2021-12-06
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.